{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:12:00Z","timestamp":1773292320772,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1053\/j.ackd.2008.12.006","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T05:29:31Z","timestamp":1235280571000},"page":"109-116","source":"Crossref","is-referenced-by-count":16,"title":["Iron and Clinical Outcomes in Dialysis and Non\u2013Dialysis-Dependent Chronic Kidney Disease Patients"],"prefix":"10.1053","volume":"16","author":[{"given":"Csaba P.","family":"Kovesdy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2008.12.006_bib1","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1371\/journal.pbio.0000079","article-title":"How mammals acquire and distribute iron needed for oxygen-based metabolism","volume":"1","author":"Rouault","year":"2003","journal-title":"PLoS Biol"},{"key":"10.1053\/j.ackd.2008.12.006_bib2","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1053\/j.ajkd.2006.03.011","article-title":"II. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Adults","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69035.x","article-title":"Iron overload in renal failure patients: Changes since the introduction of erythropoietin therapy","volume":"55","author":"Eschbach","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000107927","article-title":"Nonhematological benefits of iron","volume":"27","author":"Agarwal","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib5","first-page":"73","article-title":"Serum ferritin and iron deficiency in patients on chronic hemodialysis","volume":"22","author":"Beallo","year":"1976","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1053\/j.ackd.2008.12.006_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0272-6386(99)70079-X","article-title":"Diagnosis of iron deficiency in chronic renal failure","volume":"34","author":"Fernandez-Rodriguez","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0272-6386(95)90649-5","article-title":"Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era","volume":"26","author":"Kalantar-Zadeh","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib9","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1523-1755.2001.00077.x","article-title":"A randomized trial of iron deficiency testing strategies in hemodialysis patients","volume":"60","author":"Fishbane","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2003.00826.x","article-title":"Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients","volume":"63","author":"Kaneko","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1532\/LH96.04072","article-title":"Discrepancy between the percentage of hypochromic erythrocytes and the reticulocyte hemoglobin content in hemodialysis patients with recombinant human erythropoietin therapy","volume":"11","author":"Asanuma","year":"2005","journal-title":"Lab Hematol"},{"key":"10.1053\/j.ackd.2008.12.006_bib12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1523-1755.1999.00627.x","article-title":"Factors determining the percentage of hypochromic red blood cells in hemodialysis patients","volume":"56","author":"Bovy","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5414\/CNP58363","article-title":"Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients","volume":"58","author":"Chiang","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib14","first-page":"42","article-title":"Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients","volume":"53","author":"Canavese","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000089266","article-title":"Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?","volume":"25","author":"Malyszko","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib16","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1681\/ASN.V7122654","article-title":"The evaluation of iron status in hemodialysis patients","volume":"7","author":"Fishbane","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","article-title":"The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin","volume":"16","author":"Tessitore","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2008.12.006_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(99)70259-3","article-title":"Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients","volume":"33","author":"Gunnell","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ndt\/gfg493","article-title":"Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients","volume":"19","author":"Kalantar-Zadeh","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2008.12.006_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: Molecular properties, iron storage function and cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.ackd.2008.12.006_bib21","doi-asserted-by":"crossref","first-page":"15285","DOI":"10.1074\/jbc.270.25.15285","article-title":"Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha","volume":"270","author":"Kwak","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ackd.2008.12.006_bib22","doi-asserted-by":"crossref","first-page":"14572","DOI":"10.1016\/S0021-9258(18)77341-9","article-title":"Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1","volume":"265","author":"Rogers","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ackd.2008.12.006_bib23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1357-2725(99)00065-5","article-title":"The iron transporter DMT1","volume":"31","author":"Andrews","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1053\/j.ackd.2008.12.006_bib24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.ackd.2008.12.006_bib25","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1182\/blood-2002-08-2459","article-title":"Cytokine-mediated regulation of iron transport in human monocytic cells","volume":"101","author":"Ludwiczek","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1053\/j.ackd.2008.12.006_bib26","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2215\/CJN.01390406","article-title":"The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?","volume":"1","author":"Kalantar-Zadeh","year":"2006","journal-title":"Clin J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib27","first-page":"362","article-title":"Occult blood loss and iron balance in chronic renal failure","volume":"12","author":"Koch","year":"1976","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1053\/j.ackd.2008.12.006_bib28","first-page":"24","article-title":"The measurement of dialyzer blood loss","volume":"1","author":"Lindsay","year":"1973","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib29","first-page":"135","article-title":"Blood loss during maintenance hemodialysis","volume":"20A","author":"Longnecker","year":"1974","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1053\/j.ackd.2008.12.006_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000180862","article-title":"Iron absorption in experimental uremia","volume":"19","author":"Delano","year":"1977","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2008.12.006_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000189100","article-title":"Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test","volume":"73","author":"Goch","year":"1996","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2008.12.006_bib32","unstructured":"United States Renal Data System: The USRDS Dialysis Morbidity and Mortality Study (wave 1). 45-67. 1996. U.S. Renal Data System 1996Annual Report 4, Bethesda, MD, National Institute of Health, National Institute of Diabetes, Digestive and Kidney Diseases"},{"key":"10.1053\/j.ackd.2008.12.006_bib33","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1097\/01.ASN.0000034200.82278.DC","article-title":"Iron status and hemoglobin level in chronic renal insufficiency","volume":"13","author":"Hsu","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib34","first-page":"161","article-title":"Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron","volume":"19","author":"Gotloib","year":"2006","journal-title":"J Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib35","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.03980808","article-title":"Association of markers of iron stores with outcomes in patients with non-dialysis dependent CKD","author":"Kovesdy","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2003.12.029","article-title":"A low serum iron level is a predictor of poor outcome in hemodialysis patients","volume":"43","author":"Kalantar-Zadeh","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0272-6386(01)80014-7","article-title":"Serum ferritin is a marker of morbidity and mortality in hemodialysis patients","volume":"37","author":"Kalantar-Zadeh","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib38","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib39","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(82)92204-8","article-title":"Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy","volume":"1","author":"Ali","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2008.12.006_bib40","first-page":"101","article-title":"Serum ferritin concentration: A reliable guide to iron overload in uremic and hemodialyzed patients","volume":"10","author":"Aljama","year":"1978","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib41","first-page":"326","article-title":"Hemosiderosis in a patient on regular hemodialysis: Treatment by desferrioxamine","volume":"6","author":"Baker","year":"1976","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib42","first-page":"369","article-title":"Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload","volume":"48","author":"Gokal","year":"1979","journal-title":"Q J Med"},{"key":"10.1053\/j.ackd.2008.12.006_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000185954","article-title":"Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin","volume":"55","author":"Nomura","year":"1990","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2008.12.006_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000186162","article-title":"Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: Confirmation by follow-up liver biopsy","volume":"56","author":"Onoyama","year":"1990","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2008.12.006_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000181469","article-title":"Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients","volume":"22","author":"Pitts","year":"1978","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2008.12.006_bib46","first-page":"217","article-title":"Dialysis hemosiderosis mimicking non-A, non-B hepatitis","volume":"30","author":"Stanbaugh","year":"1984","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1053\/j.ackd.2008.12.006_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000408081","article-title":"Patterns of iron storage in patients with severe renal failure","volume":"38","author":"Van de Vyver","year":"1984","journal-title":"Contrib Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib48","doi-asserted-by":"crossref","first-page":"F370","DOI":"10.1152\/ajprenal.00300.2003","article-title":"Heme: A determinant of life and death in renal tubular epithelial cells","volume":"286","author":"Gonzalez-Michaca","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ackd.2008.12.006_bib49","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/labinvest.3780200","article-title":"Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis","volume":"80","author":"Zhou","year":"2000","journal-title":"Lab Invest"},{"key":"10.1053\/j.ackd.2008.12.006_bib50","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.ki.5002391","article-title":"Cytokine gene polymorphism and progression of renal and cardiovascular diseases","volume":"72","author":"Rao","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP68001","article-title":"Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: Sources and consequences","volume":"68","author":"Yilmaz","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib52","first-page":"170","article-title":"Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin","volume":"51","author":"Aggarwal","year":"2003","journal-title":"J Assoc Physicians India"},{"key":"10.1053\/j.ackd.2008.12.006_bib53","doi-asserted-by":"crossref","first-page":"c63","DOI":"10.1159\/000076401","article-title":"Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products","volume":"96","author":"Charytan","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ackd.2008.12.006_bib54","doi-asserted-by":"crossref","first-page":"c55","DOI":"10.1159\/000085049","article-title":"Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis","volume":"100","author":"Charytan","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ackd.2008.12.006_bib55","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1681\/ASN.2007101156","article-title":"Ferumoxytol for treating iron deficiency anemia in CKD","volume":"19","author":"Spinowitz","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib56","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/16.5.967","article-title":"A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin","volume":"16","author":"Stoves","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2008.12.006_bib57","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/j.1523-1755.2005.00758.x","article-title":"A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD","volume":"68","author":"Van Wyck","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib58","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000045053","article-title":"Correction of uremic iron deficiency anemia in hemodialyzed patients: A prospective study","volume":"79","author":"Fudin","year":"1998","journal-title":"Nephron"},{"key":"10.1053\/j.ackd.2008.12.006_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0272-6386(03)00373-1","article-title":"Safety in iron management","volume":"41","author":"Fishbane","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib61","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/ajkd.2002.33917","article-title":"Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury","volume":"40","author":"Zager","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2008.12.006_bib62","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/j.1523-1755.2004.00742.x","article-title":"Parenteral iron therapy exacerbates experimental sepsis","volume":"65","author":"Zager","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib63","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1523-1755.2004.00648.x","article-title":"Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease","volume":"65","author":"Agarwal","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib64","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ndt\/gfg031","article-title":"Carbonyl stress induced by intravenous iron during haemodialysis","volume":"18","author":"Michelis","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2008.12.006_bib65","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.ki.5002422","article-title":"Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease","volume":"72","author":"Agarwal","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2008.12.006_bib66","first-page":"1015","article-title":"von HD, Schaefer K: Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis","volume":"65","author":"Seifert","year":"1987","journal-title":"Q J Med"},{"key":"10.1053\/j.ackd.2008.12.006_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.291.6494.501","article-title":"Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: The critical role of iron overload","volume":"291","author":"Waterlot","year":"1985","journal-title":"Br Med J"},{"key":"10.1053\/j.ackd.2008.12.006_bib68","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1681\/ASN.V133734","article-title":"Iron administration and clinical outcomes in hemodialysis patients","volume":"13","author":"Feldman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2008.12.006_bib69","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","article-title":"Administration of parenteral iron and mortality among hemodialysis patients","volume":"15","author":"Feldman","year":"2004","journal-title":"J Am Soc Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559508002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559508002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T05:03:34Z","timestamp":1633151014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559508002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1548559508002139"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2008.12.006","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}